Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EHRA 25: The European Affera Ventricular Arrhythmia Ablation Registry
Author(s): Frédéric Sacher Added: 8 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9… View more

Electrophysiology & Arrhythmia
Idiopathic Annular Ventricular Arrhythmias
Author(s): Zachary T Yoneda , William G Stevenson Added: 1 year ago

Electrophysiology & Arrhythmia
Arrhythmias in Adults with Congenital Heart Disease
Author(s): Meng-Chang Lee , Chun-Wei Lu , Mei-Hwan Wu Added: 1 week ago

Electrophysiology & Arrhythmia

Inherited and Congenital Cardiac Conditions
Ventricular Tachycardia After Cardioversion
Author(s): Eiad Habib , Mahmoud Abdelnabi , Ramzi Ibrahim , et al Added: 3 weeks ago

Electrophysiology & Arrhythmia

Heart Failure
Anatomical Determinants of Papillary Muscle Arrhythmias in Apparently Normal Hearts
Author(s): Santiago Rivera , Maria de la Paz Ricapito , Ricardo Ronderos , et al Added: 4 months ago

Electrophysiology & Arrhythmia

Imaging & Diagnostics
Fascicular and Papillary Arrhythmias
Author(s): Travis D Richardson , Roy M John Added: 7 months ago

Electrophysiology & Arrhythmia
Dynamic Voltage Mapping of Ventricular Tachycardia Substrate
Author(s): Mark T Mills , Peter Calvert , Justin Chiong , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Ventricular Tachycardia Ablation: Meta-analysis of Randomised Trials
Author(s): Rohin K Reddy , James P Howard , Yousif Ahmad , et al Added: 2 years ago

Electrophysiology & Arrhythmia
POTCAST: Raising Potassium Levels Reduces Arrhythmia Risk in ICD Patients
Added: 3 months ago Source:  Arrhythmia Academy
A strategy of actively increasing plasma potassium to high-normal levels significantly lowered the risk of arrhythmia events in high-risk patients with an implantable cardioverter–defibrillator (ICD), according to results from the POTCAST trial.¹˒² The findings were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the New England Journal of… View more

Electrophysiology & Arrhythmia

Heart Failure